Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 133781 - 133800 out of 485545 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Czech Republic | (L01XE01) imatinib | IMATINIB ACCORD | 100MG, 100MG TBL FLM 60X1 I , BLJ | Retail price with vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma; Dermatofibrosarcoma; Myelodysplastic-Myeloproliferative Diseases; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Hypereosinophilic Syndrome | AccordHealthcareS.L.U.,Barcelona |
| Czech Republic | (L01XE01) imatinib | IMATINIB GLENMARK | 100MG, 100MG TBL FLM 60 , BLI | Retail price with vat |
$0-0 |
$0-0 |
n/a | GlenmarkPharmaceuticalss.r.o.,Praha |
| Czech Republic | (L01XE01) imatinib | GLIVEC | 400MG, 400MG TBL FLM 30 II , BLI | Retail price with vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma; Gastrointestinal Stromal Tumors; Dermatofibrosarcoma; Myelodysplastic-Myeloproliferative Diseases; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Hypereosinophilic Syndrome | NovartisEuropharmLimited,Dublin |
| Czech Republic | (L01XE01) imatinib | GLIVEC | 400MG, 400MG TBL FLM 90 II , BLI | Retail price with vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma; Gastrointestinal Stromal Tumors; Dermatofibrosarcoma; Myelodysplastic-Myeloproliferative Diseases; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Hypereosinophilic Syndrome | NovartisEuropharmLimited,Dublin |
| Czech Republic | (L01XE01) imatinib | IMATINIB ACCORD | 400MG, 400MG TBL FLM 30X1 I , BLJ | Retail price with vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma; Dermatofibrosarcoma; Myelodysplastic-Myeloproliferative Diseases; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Hypereosinophilic Syndrome | AccordHealthcareS.L.U.,Barcelona |
| Czech Republic | (L01XE01) imatinib | IMATINIB GLENMARK | 400MG, 400MG TBL FLM 30 , BLI | Retail price with vat |
$0-0 |
$0-0 |
n/a | GlenmarkPharmaceuticalss.r.o.,Praha |
| Czech Republic | (L01XE01) imatinib | IMATINIB TEVA PHARMA | 400MG, 400MG TBL FLM 30 I , BLI | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Myelodysplastic-Myeloproliferative Diseases; Hypereosinophilic Syndrome; Dermatofibrosarcoma | TevaPharmaB.V.,Haarlem |
| Czech Republic | (L01XE27) ibrutinib | IMBRUVICA | 140MG, 140MG CPS DUR 90 , TBC | Retail price with vat |
$0-0 |
$0-0 |
Lymphoma, Mantle-Cell; Leukemia, Lymphocytic, Chronic, B-Cell | Janssen-CilagInternationalN.V.,Beerse |
| Czech Republic | (L01XE27) ibrutinib | IMBRUVICA | 140MG, 140MG CPS DUR 120 , TBC | Retail price with vat |
$0-0 |
$0-0 |
Lymphoma, Mantle-Cell; Leukemia, Lymphocytic, Chronic, B-Cell | Janssen-CilagInternationalN.V.,Beerse |
| Czech Republic | (L01XE38) Cobimetinib | COTELLIC | 20MG, 20MG TBL FLM 63(3X21) , BLI | Retail price with vat |
$0-0 |
$0-0 |
Melanoma | RocheRegistrationGmbH,Grenzach-Wyhlen |
| Czech Republic | (L01XF03) bexarotene | TARGRETIN | 75MG, 75MG CPS MOL 100 , TBC | Retail price with vat |
$0-0 |
$0-0 |
Lymphoma, T-Cell, Cutaneous | EisaiGmbH,FrankfurtamMain |
| Czech Republic | (L01XE38) Cobimetinib | COTELLIC | 20MG, 20MG TBL FLM 63(3X21) , BLI | Retail price with vat |
$0-0 |
$0-0 |
Melanoma | RocheRegistrationGmbH,Grenzach-Wyhlen |
| Czech Republic | (L01XF03) bexarotene | TARGRETIN | 75MG, 75MG CPS MOL 100 , TBC | Retail price with vat |
$0-0 |
$0-0 |
Lymphoma, T-Cell, Cutaneous | EisaiGmbH,FrankfurtamMain |
| Czech Republic | (L01XG01) bortezomib | BORTEZOMIB ACCORD | 2,5MG/ML, 2,5MG/ML INJ SOL 1X1,4ML , VIA | Retail price with vat |
$0-0 |
$0-0 |
Multiple Myeloma | AccordHealthcareS.L.U.,Barcelona |
| Czech Republic | (L01XG01) bortezomib | BORTEZOMIB FRESENIUS KABI | 3,5MG, 3,5MG INJ PLV SOL 1 , VIA | Retail price with vat |
$0-0 |
$0-0 |
Multiple Myeloma | FreseniusKabiDeutschlandGmbH,BadHomburg |
| Czech Republic | (L01XG01) bortezomib | BORTEZOMIB REDDY | 3,5MG, 3,5MG INJ PLV SOL 1 , VIA | Retail price with vat |
$0-0 |
$0-0 |
n/a | ReddyHoldingGmbH,Augsburg |
| Czech Republic | (L01XG01) bortezomib | ZEGOMIB | 3,5MG, 3,5MG INJ PLV SOL 1 , VIA | Retail price with vat |
$0-0 |
$0-0 |
n/a | EgisPharmaceuticalsPLC,Budapešť |
| Czech Republic | (L01XE27) ibrutinib | IMBRUVICA | 140MG, 140MG CPS DUR 90 , TBC | Retail price with vat |
$0-0 |
$0-0 |
Lymphoma, Mantle-Cell; Leukemia, Lymphocytic, Chronic, B-Cell | Janssen-CilagInternationalN.V.,Beerse |
| Czech Republic | (L01XE27) ibrutinib | IMBRUVICA | 140MG, 140MG CPS DUR 120 , TBC | Retail price with vat |
$0-0 |
$0-0 |
Lymphoma, Mantle-Cell; Leukemia, Lymphocytic, Chronic, B-Cell | Janssen-CilagInternationalN.V.,Beerse |
| Czech Republic | (L01XG01) bortezomib | BORTEZOMIB EVER PHARMA | 2,5MG/ML, 2,5MG/ML INJ SOL 1X1,4ML , VIA | Retail price with vat |
$0-0 |
$0-0 |
n/a | EVER-ValinjectGmbH,UnterachamAttersee |
Pages
